Search

Michelle Olsher Phones & Addresses

  • 127 Delia Ln, Philadelphia, PA 19115 (215) 464-7215
  • 100 Van Buren Ave, Lakewood, NJ 08701 (732) 905-4408
  • 28 Kings Ct, Lakewood, NJ 08701 (732) 905-4408
  • Altamonte Springs, FL
  • Highland Park, NJ

Resumes

Resumes

Michelle Olsher Photo 1

Associate Scientific Services Director

View page
Location:
Philadelphia, PA
Industry:
Pharmaceuticals
Work:
Bioscript Science since Jan 2010
VP Scientific Services

i3 Statprobe Dec 2009 - Dec 2010
Senior Medical Writer in Oncology

Clearly Stated Scientific Writing and Editing Jan 2004 - Dec 2009
President

Temple University Medical School Jan 2006 - Aug 2008
Associate Scientist
Education:
Temple University School of Medicine
Ph.D., Biochemistry
University of Pennsylvania
BA, Biology
Skills:
Oncology
Cancer
Diabetes
Cell Culture
Therapeutic Areas
Cell
Medical Communications
Data Analysis
Cardiovascular Disease
Manuscript
Editing
Medicine
Teaching
Training
Science
Michelle Olsher Photo 2

Scientific Director

View page
Location:
Philadelphia, PA
Work:
Clinicalthinking
Scientific Director
Education:
Temple University - Lewis Katz School of Medicine 1998 - 2004
Doctorates, Doctor of Philosophy

Business Records

Name / Title
Company / Classification
Phones & Addresses
Michelle S. Olsher
Principal
Clearly Stated, LLC
Business Services at Non-Commercial Site
127 Delia Ln, Philadelphia, PA 19115

Publications

Us Patents

An Assay For Screening/Ranking Antioxidants Based On Their Effects On Membrane Sterol Lateral Organization

View page
US Patent:
20100291687, Nov 18, 2010
Filed:
Jul 25, 2008
Appl. No.:
12/668330
Inventors:
Parkson Lee-Gau CHONG - Cherry Hill NJ, US
Michelle OLSHER - Philadelphia PA, US
Su-In YOON - Singapore, SG
Assignee:
TEMPLE UNIVERSITY- OF THE COMMONWEATH SYSTEM OF HIGHER EDUCATION - Philadelphia PA
International Classification:
G01N 31/00
G01N 33/92
US Classification:
436 13, 436 71
Abstract:
A method of screening an antioxidant for potency and/or toxicity in vitro, the method includes contacting the antioxidant with a model system comprising a sterol superlattice formation capable of generating a detectable signal, wherein the detectable signal changes in a parameter representative of an integrity of the sterol superlattice formation; and detecting and/or measuring disruption of the sterol superlattice formation, wherein the disruption is caused by oxidation of sterol upon contacting sterol with a prooxidant and the antioxidant and thereby screening the antioxidant for potency and/or toxicity.
Michelle S Olsher from Philadelphia, PA, age ~62 Get Report